Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology - a subgroup analysis of a multicenter, phase III trial

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Muecke, Ralph ^a   Micke, Oliver ^b   Schomburg, Lutz ^c   Buentzel, Jens ^d   Glatzel, Michael ^e   Baaske, Dieter ^f   Berndt Skorka, Regina ^g   Prott, Franz J ^h   Reichl, Berthold ⁱ   Kisters, Klaus ^j   Schaefer, Ulrich ^a   Huebner, Jutta ^k   Eich, Hans Th ^l   Kundt, Guenther ^m   Adamietz, Irenaeus A ⁿ  

^a LIPPE HOSPITAL   (Germany)

^b FRANZISKUS HOSPITAL   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Sudharz Hospital   (Germany)

^e Municipal Hospital   (Germany)

^f Municipal Hospital   (Germany)

^g Municipal Hospital   (Germany)

^h ST JOSEFS HOSPITAL   (Germany)

ⁱ Municipal Hospital   (Germany)

^j ST ANNA HOSPITAL   (Germany)

^k GOETHE UNIVERSITY   (Germany)

^l UNIVERSITY OF MÜNSTER   (Germany)

^m UNIVERSITY OF ROSTOCK   (Germany)

ⁿ RUHR UNIVERSITY BOCHUM   (Germany)

more..

Author keywords

Planning target volume; Radiation induced diarrhoea; Selenium administration in gynecologic radiation oncology

Indexed keywords

SODIUM SELENITE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; COMPUTER PROGRAM; CONTROLLED STUDY; DIARRHEA; ENDOMETRIUM CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PLANNING TARGET VOLUME; RADIATION SICKNESS; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; TREATMENT PLANNING; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; DIARRHEA; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MIDDLE AGED; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; SELENIUM; SODIUM SELENITE; UTERINE CERVICAL NEOPLASMS;

EID: 84875308523     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-72     Document Type: Article

References (29)

1. Micke O, Muecke R, Buentzel J, Kisters K, Schaefer U. Some more steps on the way to clinical elementology. Trace Elem Electrolytes 2010, 27:29-34.
2. Rayman MP. Selenium and human health. Lancet 2012, 379:1256-1268. 10.1016/S0140-6736(11)61452-9, 22381456.
3. Schomburg L, Schweizer U, Koehrle J. Selenium and selenoproteins in mammals: extraordinary, essential, enigmatic. Cell Mol Life Sci 2004, 61:1988-1995.
4. Hoefig CS, Renko K, Köhrle J, Birringer M, Schomburg L. Comparison of different selenocompounds with respect to nutritional value vs. toxicity using liver cells in culture. J Nutr Biochem 2011, 22:945-955. 10.1016/j.jnutbio.2010.08.006, 21190829.
5. Muecke R, Micke O, Schomburg L, Buentzel J, Kisters K, Adamietz IA. Selenium in radiation oncology - experiences and prospects. Trace Elem Electrolytes 2011, 28:168-177.
6. Buentzel J, Muecke R, Micke O. Mineral status and enzymatic antioxidative capacities during radiochemotherapy in patients with advanced head and neck cancer. Trace Elem Electrolytes 2011, 18:98.
7. Buentzel J, Micke O, Muecke R, Schoenekaes KG, Schaefer U, Kisters K, Bruns F. Amifostine and selenium during simultaneous radiochemotherapy In head and neck cancer - redox status data. Trace Elem Electrolytes 2005, 22:211-215.
8. Asfour IA, El-Tehewi MM, Ahmed MH, Abdel-Sattar MA, Moustafa NN, Hegab HM, Fathey OM. High-dose sodium selenite can induce apoptosis of lymphoma cells in adult patients with non Hodgkin's lymphoma. Biol Trace Elem Res 2009, 127:200-210. 10.1007/s12011-008-8240-6, 18953506.
9. Buentzel J, Micke O, Glatzel M, Schaefer U, Riesenbeck D, Kisters K, Bruns F, Schoenekaes KG, Dawczynski H, Muecke R. Selenium substitution during radiotherapy in head and neck cancer. Trace Elem Electrolytes 2010, 27:235-239.
10. Sieja K, Talerczyk M. Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy. Gynecol Oncol 2004, 93:320-327. 10.1016/j.ygyno.2003.12.013, 15099940.
11. Weijl NI, Elsendoorn TJ, Lentjes EG, Hopman GD, Wipkink-Bakker A, Zwinderman AH, Cleton FJ, Osanto S. Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study. Eur J Cancer 2004, 40:1713-1723. 10.1016/j.ejca.2004.02.029, 15251161.
12. Last KW, Cornelius V, Delves T, Sieniawska CH, Fitzgibbon J, Norton A, Amess J, Wilson A, Rohatiner A, Lister AT. Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkińs lymphoma. J Clin Oncol 2003, 21:2335-2341. 10.1200/JCO.2003.06.145, 12805335.
13. Last K, Maharaj L, Perry J, Strauss S, Fitzgibbon J, Lister TA, Joel S. The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours. Ann Oncol 2006, 17:773-779. 10.1093/annonc/mdl004, 16469755.
14. Buentzel J, Riesenbeck D, Glatzel M, Berndt-Skorka R, Riedel T, Muecke R, Kisters K, Schoenekaes KG, Schaefer U, Bruns F, Micke O. Limited effects of selenium substitution in the prevention of radiation-associated toxicities. Results of a randomized study in head neck cancer patients. Anticancer Res 2010, 30:1829-1832.
15. Muecke R, Schomburg L, Glatzel M, Bernd-Skorka R, Baaske D, Reichl B, Buentzel J, Kundt G, Prott FJ, De Vries A, Stoll G, Kisters K, Bruns F, Schaefer U, Willich N, Micke O. Multicenter, phase III trial comparing selenium supplementation with observation in gynecologic radiation oncology. Int J Radiat Oncol Biol Phys 2010, 70:828-835.
16. Winnefeld K, Dawczynski H, Schirrmeister W, Adam G, Friedrich U, Hein S. Selenium in serum and whole blood in patients with surgical interventions. Biol Trace Elem Res 1995, 50:149-155. 10.1007/BF02789417, 8605082.
17. Baliga MS, Diwadkar-Navsariwala V, Koh T, Fayad R, Fantuzzi G, Diamond AM. Selenoprotein deficiency enhances radiation-induced micronuclei formation. Mol Nutr Food Res 2008, 52:1300-1304. 10.1002/mnfr.200800020, 18720346.
18. Seo YR, Kelley MK, Smith ML. Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc Natl Acad Sci 2002, 99:14548-14553. 10.1073/pnas.212319799, 137920, 12357032.
19. Gudkov AV. Converting p53 from a killer to a healer. Nat Med 2002, 8:1196-1198. 10.1038/nm1102-1196, 12411937.
20. Fischer JL, Mihelc EM, Pollok KE, Smith ML. Chemotherapeutic selectivity conferred by selenium: a role for p53-dependent DNA repair. Mol Cancer Ther 2007, 6:355-361. 10.1158/1535-7163.MCT-06-0472, 17237294.
21. Tsavachidou D, McDonnell TJ, Wen S, Wang X, Vakar-Lopez F, Pisters LL, Pettaway CA, Wood CG, Do KA, Thall PF, Stephens C, Efstathiou E, Taylor R, Menter DG, Troncoso P, Lippman SM, Logothetis CJ, Kim J. Selenium and Vitamin E: Cell Type- and Intervention-Specific Tissue Effects in Prostate Cancer. J Natl Cancer Inst 2009, 101:306-320. 10.1093/jnci/djn512, 2734116, 19244175.
22. Meyer HA, Hollenbach B, Stephan C, Endermann T, Morgenthaler NG, Cammann H, Kohrle J, Jung K, Schomburg L. Reduced serum Selenoprotein P concentrations in German prostate cancer patients. Cancer Epidemiol Biomarkers Prev 2009, 18:2386-2390. 10.1158/1055-9965.EPI-09-0262, 19690186.
23. Beck MA, Nelson HK, Shi Q, Van Dael P, Schiffrin EJ, Blum S, Barclay D, Levander OA. Selenium deficiency increases the pathology of an influenza virus infection. FASEB J 2001, 15:1481-1483.
24. Vunta H, Davis F, Palempalli UD, Bhat D, Arner RJ, Thompson JT, Peterson DG, Reddy CC, Prabhu KS. The anti-inflammatory effects of selenium are mediated through 15-deoxy-Delta12,14 prostaglandin J2 in macrophages. J Biol Chem 2007, 282:17964-17973. 10.1074/jbc.M703075200, 17439952.
25. Duntas LH. Selenium and inflammation: underlying anti-inflammatory mechanisms. Horm Metab Res 2009, 41:443-447. 10.1055/s-0029-1220724, 19418416.
26. Gehrisch A, Doerr W. Effects of systemic or topical administration of sodium selenite on early radiation effects in mouse oral mucosa. Strahlenther Onkol 2007, 183:36-42. 10.1007/s00066-007-1594-4, 17225944.
27. Dennert G, Horneber M. Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients. Cochrane Database of Systematic Reviews 2011(Issue 6):CD005037. 2006 3. Issue/10.1002/14651858.CD005037.pub2.
28. Muecke R, Schomburg L, Buentzel J, Kisters K, Micke O. Blood selenium status in tumor patients: Omnia sunt venena, nihil est sine veneno. Sola dosis facit venenum. Trace Elem Electrolytes 2010, 27:181-182.
29. Muecke R, Schomburg L, Buentzel J, Kisters K, Micke O. Selenium or no selenium-that is the question in tumor patients: a new controversy. Integr Cancer Ther 2010, 9:136-141. 10.1177/1534735410367648, 20462857.